Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

6,511 total articles

Fortinet: Ride the AI-Security Wave While Managing Rich Valuation

Fortinet: Ride the AI-Security Wave While Managing Rich Valuation

Fortinet is trading near its 52-week high as AI-driven security demand and cloud workload protection lift growth expectations. Fundamentals show robust free cash flow ($2.44B trailing) and high profitability metrics, while technicals point to bullish momentum and short interest that can fuel further moves. This trade idea sets an entry at $126.56 w…

IREN’s AI Ambition Is Real — But Buy the Pullback, Not the Hype

IREN’s AI Ambition Is Real — But Buy the Pullback, Not the Hype

IREN is transitioning from crypto-mining roots to a power-hungry AI infrastructure play backed by multi-billion dollar leases. The stock has run, sentiment is mixed, and the balance sheet and cash flow are still strained. This trade buys a measured pullback with clear risk controls: entry $50.00, stop $46.00, target $68.00 over a mid-term (45 tradi…

CenterPoint: Positioned to Power the Data Center Buildout

CenterPoint: Positioned to Power the Data Center Buildout

CenterPoint Energy is quietly reshaping its business toward electrification and large-scale infrastructure projects that serve data centers and AI customers. With partnerships that tie its grid operations to enterprise AI platforms, a $2.62B divestiture that reduces gas exposure, a 2.13% yield and a market cap near $27.3B, CNP looks like a practica…

Telix (TLX): PSMA Radiopharma Momentum and a Clear Risk/Reward Trade

Telix (TLX): PSMA Radiopharma Momentum and a Clear Risk/Reward Trade

Telix Pharmaceuticals is threading multiple clinical and commercial catalysts into 2026: an FDA PDUFA for its glioma imaging agent, expanded clinical data for kidney imaging, low-toxicity dosimetry for its next-gen PSMA therapeutic, and a partnership with Regeneron that brings $40M up front plus sizable upside. With market cap at roughly $3.49B and…

Zscaler: Buy the AI-Secularity Rebound Ahead of Earnings

Zscaler: Buy the AI-Secularity Rebound Ahead of Earnings

Zscaler is trading off its 52-week highs but shows clear momentum and fundamental support as enterprises prioritize AI-safe cloud security. Strong free cash flow, accelerating technical momentum and a rising short-interest backdrop create a favorable asymmetric trade into earnings. This idea gives an entry at $177.21, a stop at $150.00 and a long-t…

Buy the Dip: Regeneron Looks Oversold After a Narrow Melanoma Miss

Buy the Dip: Regeneron Looks Oversold After a Narrow Melanoma Miss

Regeneron plunged after a Phase 3 fianlimab combination narrowly missed statistical significance for PFS (p=0.0627). The drop creates a tactical buying opportunity. The company still generates strong free cash flow, has low leverage, and multiple near-term catalysts. This trade idea grades REGN higher and lays out entry, stop, and target levels acr…

Buy MUFG on Earnings Upside and Improving ROE - Tactical Swing Trade

Buy MUFG on Earnings Upside and Improving ROE - Tactical Swing Trade

Mitsubishi UFJ Financial Group posted an earnings beat and is showing signs of return-on-equity expansion amid a higher-yield environment and a weakening yen. Valuation is reasonable (P/E ~13.3, P/B ~1.52) and technical momentum is constructive. We lay out a mid-term swing trade to capture further upside while keeping defined risk controls.